Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis
PLOS ONE · 12.09.2024 · 19 (9) · e0310017
DOI: 10.1371/journal.pone.0310017 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 12.09.2024. Verfasst von Haojie Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhoukou Central Hospital Affiliated to Xinxiang Medical University, Zhoukou City, Henan Province, China. Hauptthemen laut MEDLINE: Liver Cirrhosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to examine the potential correlation between myosteatosis and the prognosis of patients diagnosed with liver cirrhosis by a meta-analysis.
Methods
Cohort studies of relevance were acquired through comprehensive searches of the Medline, Web of Science, and Embase databases. To account for heterogeneity, a random-effects model was employed to combine the findings.
Results
The meta-analysis included 10 retrospective and four prospective cohort studies, encompassing a total of 4287 patients diagnosed with cirrhosis. The pooled findings indicated a notable decline in transplant-free survival (TFS) among individuals with liver cirrhosis and myosteatosis compared to those without this condition (risk ratio: 1.94; 95% confidence interval: 1.61 to 2.34, p < 0.001; I 2 = 49%). The predefined subgroup analyses demonstrated consistent findings across various categories, including Asian and non-Asian studies, prospective and retrospective cohort studies, patients with cirrhosis overall and those who underwent transjugular intrahepatic portosystemic shunt, studies with different follow-up durations (< or ≥ 24 months), studies employing univariate and multivariate analyses, and studies with and without an adjustment for sarcopenia ( p > 0.05 for all subgroup differences). Additionally, Egger’s regression test indicated the presence of significant publication bias ( p = 0.044). However, trim-and-fill analysis by including three hypothesized studies showed consistent results.
Conclusions
The presence of myosteatosis in individuals diagnosed with liver cirrhosis may potentially be linked to a poor TFS prognosis. Further investigations are required to ascertain whether enhancing myosteatosis could potentially yield a survival advantage for this particular patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Zhoukou Central Hospital Affiliated to Xinxiang Medical University, Zhoukou City, Henan Province, China.
- Ward 1, Department of Gastroenterology, Zhoukou Central Hospital, Zhoukou City, Henan Province, China.
- Zhoukou Central Hospital, Zhoukou City, Henan Province, China.
ORCID-Profile: Junying Liu
Zitieren
APA
Xue, H., Liu, Y., Liu, Y., Li, H., Liang, Q., Ma, L., Liu, J., & Zhao, M. (2024). Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis. PLOS ONE, 19(9), e0310017. https://doi.org/10.1371/journal.pone.0310017
Vancouver
Xue H, Liu Y, Liu Y, Li H, Liang Q, Ma L, et al. Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis. PLOS ONE. 2024;19(9):e0310017. doi:10.1371/journal.pone.0310017
BibTeX
@article{Xue2024,
author = {Xue, Haojie and Liu, Yihan and Liu, Yang and Li, Han and Liang, Qian and Ma, Longhui and Liu, Junying and Zhao, Ming},
title = {Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {9},
pages = {e0310017},
doi = {10.1371/journal.pone.0310017}
}
EUVIMED